A double-blind, controlled study of botulinum toxin A in chronic myofascial pain.
Richards
Bruce A
BA
Jensen
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D018849:Controlled Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D006801:Humans; D007273:Injections, Intramuscular / Q000592:standards; D018482:Muscle, Skeletal / Q000033:anatomy & histology / Q000187:drug effects / Q000503:physiopathology; D009209:Myofascial Pain Syndromes / Q000188:drug therapy* / Q000503:physiopathology; D009465:Neuromuscular Agents / Q000008:administration & dosage; D018579:Patient Selection; D011843:Radiculopathy / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A